Search results for "PROGNOSIS"

showing 10 items of 2052 documents

The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ven…

2007

Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), which is a validated instrument that assesses the functional status and the disease progression in patients with amyotrophic lateral sclerosis (ALS), predicts hospital length of stay and survival time in ALS patients treated with tracheostomy-intermittent positive-pressure ventilation (TIPPV). Methods: Thirty-three consecutive ALS patients with acute respiratory failure who received therapy with TIPPV were prospectively followed up from their admission to the hospital until death. The association of ALSFRS score at hospital admission with length of hospital stay and survival after TIPPV were …

Pulmonary and Respiratory MedicineArtificial ventilationMalemedicine.medical_specialtymedicine.medical_treatmentCritical Care and Intensive Care MedicineSeverity of Illness Indexlaw.inventionIntermittent Positive-Pressure VentilationlawPredictive Value of TestsInternal medicineSickness Impact ProfileSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsMechanical ventilationProportional hazards modelbusiness.industryHazard ratioAmyotrophic Lateral SclerosisLength of StayMiddle AgedPrognosisIntensive care unitSurgeryRespiratory failureAcute DiseaseDisease ProgressionSettore MED/26 - NeurologiaFemaleCardiology and Cardiovascular MedicinebusinessRespiratory InsufficiencyChest
researchProduct

Pleuropulmonary changes induced by ergoline drugs.

1996

Classic ergolines, such as bromocriptine, methysergide and ergotamine, can induce chronic pleuropneumonitis. We present the cases of eight patients who developed similar changes whilst on other ergolines. In this retrospective case study spanning 1985-1995, clinical data, radiological material, pulmonary function, bronchoalveolar lavage and histopathology were reviewed. Earlier literature on ergoline-induced pleuropulmonary changes was reviewed. Eight middle-aged to elderly individuals of both sexes developed pleuropulmonary changes during long-term therapy with regular dosages of nicergoline (n = 4), dihydroergocristine (n = 3), or dihydroergotamine (n = 1). Bibasilar pleural thickening wi…

Pulmonary and Respiratory MedicineLung DiseasesMalePleural effusionDihydroergotamineDihydroergocristineBronchoalveolar LavagePleural diseasemedicineHumansErgolinesAgedAged 80 and overmedicine.diagnostic_testbusiness.industryRespiratory diseaseBiopsy NeedleMiddle AgedPleural Diseasesmedicine.diseasePrognosisNicergolineRespiratory Function TestsSurvival RateBronchoalveolar lavageEffusionAnesthesiaFemalebusinessLung Diseases InterstitialTomography X-Ray Computedmedicine.drugThe European respiratory journal
researchProduct

The lung in inflammatory bowel disease.

2000

Pulmonary and Respiratory MedicineLung Diseasesmedicine.medical_specialtyLungbusiness.industryMEDLINEmedicine.diseasePrognosisInflammatory bowel diseaseGastroenterologyText miningmedicine.anatomical_structureCrohn DiseaseX ray computedInternal medicineMedicineHumansColitis UlcerativeColitisbusinessTomography X-Ray ComputedThe European respiratory journal
researchProduct

A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection.

2012

Objectives: We aimed to identify a phenotype of ascending thoracic aortic aneurysm (TAA), which, more than others, evolves into type A dissection (TAD). Methods: Aortic specimens were obtained from patients undergoing surgical repair of TAA and TAD (108 and 26, respectively). Histopathological and immunohistochemical analyses were performed by using adequate tissue specimens, appropriate techniques and criteria. Results: We identified the three following TAA phenotypes: phenotype I (cystic medial degeneration balanced by a substitutive fibrosis, in absence of medial apoptosis and with a faint collagenase concentration), phenotype II (cystic medial degeneration of higher grade, respectively,…

Pulmonary and Respiratory MedicineMalePathologymedicine.medical_specialtyAorta ThoracicApoptosisThoracic aortic aneurysmAortic aneurysmAneurysmFibrosismedicine.arteryAscending aortamedicineSettore MED/05 - Patologia ClinicaThoracic aortaHumansAgedAortic dissectionAortaAortic Aneurysm Thoracicbusiness.industryDissectionSettore MED/23 - Chirurgia CardiacaOriginal ArticlesMiddle Agedmedicine.diseasePrognosisAneurysmFibrosisImmunohistochemistryAortic DissectionPhenotypeMatrix Metalloproteinase 9Disease ProgressionSurgeryFemaleThoracic aortic aneurysm phenotype IIICardiology and Cardiovascular MedicinebusinessAneurysm ; Dissection ; Thoracic aortic aneurysm phenotype IIIBiomarkersInteractive cardiovascular and thoracic surgery
researchProduct

Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients.

2008

To evaluate the influence of respiratory muscle overload and right cardiac overload among the possible risk factors of hospital readmission in a 1-year follow-up of a cohort of patients with moderate-to-severe COPD.A total of 112 COPD patients who were admitted consecutively to the hospital for acute exacerbation. At hospital discharge, we evaluated the conventional clinical and functional determinations in addition to the pressure-time index (PTI), which is obtained using the equation PTI = (Pawo/Pimax) x (Ti/Ttot) x 100, where Pawo represents the mean airway pressure measured at the mouth during spontaneous breathing, Pimax is the maximal inspiratory pressure, Ti is the inspiratory time, …

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyExacerbationmedicine.medical_treatmentAtrial Function RightKaplan-Meier EstimateMean airway pressureCritical Care and Intensive Care MedicinePatient ReadmissionCohort StudiesElectrocardiographyPulmonary Disease Chronic ObstructivePredictive Value of TestsInternal medicineOxygen therapymedicineRespiratory muscleHumansAgedProportional Hazards ModelsCOPDmedicine.diagnostic_testbusiness.industryRespiratory diseaseOxygen Inhalation TherapyMiddle Agedmedicine.diseasePrognosisRespiratory MusclesSurgeryRespiratory Function TestsInhalationCardiologyBreathingVentricular Function RightCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesChest
researchProduct

New horizons in early stage COPD--improving knowledge, detection and treatment.

2011

SummaryEarly stage COPD carries a significant healthcare burden that is currently underrecognised, underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to advanced disease, especially if they continue to smoke. The natural history of the disease in early stages remains largely unknown, and emerging evidence indicates that we are able to reduce lung function decline and exacerbations, and improve quality of life, in early stage COPD, mainly through smoking cessation. But new evidence from randomised clinical trials also suggests an impact of pharmacotherapy on clinical outcomes in early disease. Guidelines need to be updated to reflect this greater underst…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentDiseasePulmonary Disease Chronic ObstructiveQuality of life (healthcare)PharmacotherapyHealth careDiagnosismedicineCOPDHumansIntensive care medicineCOPDbusiness.industryCase-findingEarly diseasemedicine.diseasePrognosisBronchodilator AgentsClinical trialNatural historyTreatmentEarly DiagnosisSpirometryPractice Guidelines as TopicPhysical therapyQuality of LifeSmoking cessationFemaleSmoking CessationbusinessRespiratory medicine
researchProduct

Prognostic Value of the 6-Min Walk Test After Open-Heart Valve Surgery: EXPERIENCE OF A CARDIOVASCULAR REHABILITATION PROGRAM

2018

PURPOSE: This single-center retrospective analysis aimed to evaluate the prognostic relevance of 6-min walk test (6MWT) in patients admitted to an in-hospital cardiovascular rehabilitation program after open-heart valve surgery. METHODS: One hundred one patients able to perform a 6MWT within the first week of admission (time after surgery: 16 ± 8 d) were included (age 68 ± 11 y; 55% female; median left ventricular ejection fraction 55% [interquartile range: 50-60]; 51% after aortic valve surgery). Study endpoints were cardiovascular death and the combined outcome of cardiovascular death/cardiac hospitalization. Univariate and multivariate analyses were performed to analyze predictive value …

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHeart Valve DiseasesWalk Test030204 cardiovascular system & hematologyPatient Readmission03 medical and health sciences0302 clinical medicineInterquartile rangePredictive Value of TestsInternal medicineNatriuretic Peptide BrainmedicineHumans030212 general & internal medicineCardiac Surgical ProceduresSurvival rateAgedRetrospective StudiesEjection fractionCardiac Rehabilitationbusiness.industryRehabilitationHazard ratioRetrospective cohort studyStroke VolumeStroke volumeLength of StayMiddle AgedBrain natriuretic peptidePrognosisPeptide FragmentsSurvival RateROC CurvePredictive value of testsArea Under CurveCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up Studies
researchProduct

Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism.

2018

VTE-BLEED predicts fatal and/or intracranial bleeding in patients with venous thromboembolism treated with long-term anticoagulants http://ow.ly/3hqg30iXK5a

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyMEDLINEHemorrhage030204 cardiovascular system & hematologySeverity of Illness Indexlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawPredictive Value of TestsRecurrenceSeverity of illnessMedicineHumansIn patientcardiovascular diseases030212 general & internal medicineAgedbusiness.industryAnticoagulantsVenous ThromboembolismBleedMiddle Agedequipment and suppliesPrognosisSurgeryPredictive value of testsDisease ProgressionFemalebusinessVenous thromboembolismIntracranial bleedingThe European respiratory journal
researchProduct

Tracheostomy in patients with long-term mechanical ventilation: a survey.

2010

Summary Background Tracheostomy is increasingly performed in intensive care units (ICU), with many patients transferred to respiratory ICU (RICU). Indications/timing for closing tracheostomy are discussed. Aim and Method We report results of a one-year survey evaluating: 1) clinical characteristics, types of tracheostomy, complications in patients admitted to Italian RICU in 2006; 2) clinical criteria and systems for performing decannulation, and outcome of patients undergoing tracheostomy (number decannulated; number non-decannulated/non-ventilated; number non-decannulated/ventilated; dead/lost patients). Results 22/32 RICUs replied. There were 846 admissions of 719 patients (Mean age 64,3…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPercutaneousSettore MED/09 - Medicina InternaExacerbationCritical Caremedicine.medical_treatmentRespiratory failureSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionTracheostomylawIntensive caremedicineHumansIn patientIntensive care unitMechanical ventilationbusiness.industryLong-term mechanical ventilationMiddle Agedmedicine.diseasePrognosisIntensive care unitRespiration ArtificialSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSurgeryObstructive sleep apneaTreatment OutcomeRespiratory failureItalyHealth Care SurveysTracheostomy Intensive care unit Long-term mechanical ventilation Respiratory failureFemalebusinessRespiratory InsufficiencyVentilator Weaning
researchProduct

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

2018

To externally validate the prognostic impact of copeptin, either alone or integrated in risk stratification models, in pulmonary embolism (PE), we performed a post hoc analysis of 843 normotensive PE patients prospectively included in three European cohorts.Within the first 30 days, 21 patients (2.5%, 95% CI 1.5–3.8) had an adverse outcome and 12 (1.4%, 95% CI 0.7–2.5) died due to PE. Patients with copeptin ≥24 pmol·L−1 had a 6.3-fold increased risk for an adverse outcome (95% CI 2.6–15.5, p<0.001) and a 7.6-fold increased risk for PE-related death (95% CI 2.3–25.6, p=0.001). Risk classification according to the 2014 European Society of Cardiology (ESC) guideline algorithm identified 248…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyValidation studyAdverse outcomes030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineCopeptinRisk groupsRisk FactorsInternal medicinePost-hoc analysismedicineHumansProspective StudiesAgedAged 80 and overbusiness.industryGlycopeptidesMiddle Agedmedicine.diseasePrognosisPulmonary embolismIncreased riskLogistic Models030228 respiratory systemROC CurveRisk stratificationFemalebusinessPulmonary EmbolismAlgorithmsBiomarkersThe European respiratory journal
researchProduct